US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biomarkers Market Research Reports & Industry Analysis

The high specificity required of biomarkers in research, drug development and clinical diagnostics creates significant diversity in the global biomarkers market. The greatest focus in biomarkers development is oncology with cancer biomarkers occupying the largest space at over 25% of the market. Biomarkers are parameters or analytes integral to or associated with a biochemical, anatomical, pathogenic, pharmacologic or molecular (genetic) process of clinical interest.

Biomarker discovery continues to power the development of in vitro diagnostic (IVD) tests used to diagnose disease and health conditions, predict patient response to therapy, and monitor therapeutic effects and patient health. Ideal biomarkers have excellent sensitivity and specificity in terms of identifying disease, determining disease state, or evaluating patient response to therapy. Biomarkers are generally proteins (products of gene expression) or nucleic acid sequences (either RNA or DNA); small molecules that are products of metabolism may also serve as biomarkers.

The proliferation of biomarkers is a result of greater clinical understanding of the interconnections between genetics, proteomics and gene expression, disease susceptibility, disease manifestation, and disease susceptibility to select therapies. Biomarkers can be classified as natural history markers (allow for the detection and isolation of a particular cell type), drug activity markers (indicate patient response to pharmological intervention), or surrogate markers (markers that can be used as an alternative to traditional endpoints such as morbidity and mortality to evaluate the effectiveness of a therapy in treating disease). Genomic research is expected to further expand the availability of biomarkers for various diseases and make significant contributions to personalized medicine.

In addition to cancer biomarkers, biomarkers are also available for cardiac function and episodes, other cardiovascular conditions, coagulation or hemostasis, endocrine function, blood sugar management, autoimmune disorders, inflammation, specific infectious diseases, sepsis, and neurological disorders. Over half of the biomarkers market exists in clinical applications, the rest in drug development, research and clinical trial applications. Biomarkers are broadly used for disease risk assessment, diagnosis, screening, treatment or therapy selection, and therapeutic monitoring.

RSS Feeds

Biomarkers Industry Research & Market Reports

< prev 1    3  4  5  6  
Global Biomarker Partnering 2010-2015: Deal trends, players, financials and forecasts
5/1/2015 | published by: Current Partnering
... agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Global Biomarker Partnering ...  |  read more...
USD 2,995
Biomarker Deals and Alliances of 2014
3/1/2015 | published by: Current Partnering
... during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Growth Drivers for Biomarkers in Healthcare
3/5/2015 | published by: Frost & Sullivan
... North America is the highest revenue-generating region with $?? billion revenue in 2014, accounting for ??% of the total global biomarkers market. Genomics is the highest revenue-generating segment with a revenue of $?? billion in ...  |  read more...
USD 3,500
Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)
9/4/2014 | published by: Kalorama Information
... proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles of proteins, and interactions of proteins. Proteomics is a large field that has focused on ...  |  read more...
USD 4,200
Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)
8/8/2014 | published by: Kalorama Information
... with several of them part of a routine diagnostic and treatment plan. This report tracks these developments and provides detailed examples of drug-test pairs.  It also provides market estimation and forecast models for business planning. ...  |  read more...
USD 3,995
miRNA Research and Diagnostics Markets
9/4/2014 | published by: Kalorama Information
... the post-transcriptional level. These small bits of RNA, members of a class of non-translated molecules that do not produce protein, shut off gene transcription by base pairing with the target molecules.  They are now recognized as ...  |  read more...
USD 2,995
Emerging Diagnostic Imaging Market – Devices (Nuclear Imaging Systems, 3D imaging, Tactile imaging, Tomography, Emerging Diagnostic Biomarkers, Wearable diagnostic devices), Global Industry Analysis, Growth, Trends, Forecast, Growth, Strategies and Opport
1/15/2015 | published by: Occams Business Research & Consultancy
... Technologies provide imagery feedback on a patient’s physical condition, which is then used to diagnose, monitor or treat medical conditions, thus playing an important role in improving public health of all age groups. X-ray based ...  |  read more...
USD 4,000
Renal Biomarkers: Technologies and Global Markets
1/1/2015 | published by: BCC Research
... billion by 2019, a compound annual growth rate (CAGR) of 7% from 2014 to 2019. This report provides: A comprehensive analysis of renal biomarkers global markets and technologies. Analyses of global market trends, with data ...  |  read more...
USD 6,650
Global Cancer Biomarkers Market 2015-2019
1/14/2015 | published by: TechNavio - Infiniti Research Ltd.
... Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs. Biomarkers are becoming an essential part of the drug discovery process. ...  |  read more...
USD 2,500
MicroRNAs in Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... perhaps even more likely in a combinatorial drug setting. miRNA may also hold great potential as biomarkers, albeit a lot of work is a head of us and the industry hasn't really caught up with ...  |  read more...
USD 6,746
Stroke Diagnostics and Therapeutics: Global Markets
2/1/2015 | published by: BCC Research
... 2019, with a compound annual growth rate (CAGR) of 7% from 2014 to 2019. This report provides: An overview of the global market for stroke therapeutics and diagnostics. Analyses of market trends, with data from ...  |  read more...
USD 6,650
Cardiac Marker Diagnostic Testing Markets
1/1/2015 | published by: TriMark Publications
... cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF) and atherosclerosis. Every year, an estimated 17 million people worldwide die from a CVD. This TriMark Publications report describes the specific market segment of ...  |  read more...
USD 3,400
Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) – Global Forecast to 2023
9/10/2014 | published by: MarketsandMarkets
... diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market The product segment is expected to account for the largest share of the human microbiome market in the ...  |  read more...
USD 4,650
Conference Documentation: Advances in Cell Based Assays
11/11/2014 | published by: SMI Publishing, Ltd
... and strategies to accelerate go/no-go decision making in early and clinical development. Key academic, government and industry figures cover topics encompassing: Case studies in idiopathic pulmonary fibrosis (IPF) and molecular characterisation of solid tumors Interactive ...  |  read more...
USD 788.78
Biomarker Partnering Terms and Agreements
11/1/2014 | published by: Current Partnering
... partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and ...  |  read more...
USD 2,995
2014-2018 World Tumor Marker Testing Market Overview: Test Volume and Sales Forecasts by Country
11/12/2014 | published by: VPGMarketResearch.com
... well as ten-year test volume and sales forecasts by country. Contains 11 pages and 3 tables Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow ...  |  read more...
USD 2,450
2014-2018 Global CA Tumor Markers Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan
11/4/2014 | published by: VPGMarketResearch.com
... the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ...  |  read more...
USD 5,450
2014-2018 European Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
11/12/2014 | published by: VPGMarketResearch.com
... major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players ...  |  read more...
USD 19,700
2014-2018 World Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
11/12/2014 | published by: VPGMarketResearch.com
... opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; ...  |  read more...
USD 34,500
Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024
6/25/2014 | published by: Visiongain
... medicines? Now get the latest analysis for that industry. There you explore developments (R&D), results, opportunities, trends and revenue forecasts. Visiongain’s updated report shows you what’s possible for those drugs, diagnostic tests and related technology. ...  |  read more...
USD 2,914
USD 4,850
USD 3,850
USD 3,850
POCT Market in China : 2014-2018
9/10/2014 | published by: TechNavio - Infiniti Research Ltd.
... is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the ...  |  read more...
USD 2,500
Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders
7/1/2014 | published by: CHI Insight Pharma Reports
... development. Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders. Although there are many techniques used to track neurodegenerative disease progression, this report will ...  |  read more...
USD 2,495
< prev 1    3  4  5  6